References
- Müller J., Wallukat G., Dandel M., Biede H., Brandes K., Spiegelberger B., Nissen E. R., Kunze R., Hetzer R. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000; 101: 385–391
- Matsui S., Fu M. L. X., Katsuda S., Hayase M., Yamaguchi N., Teraoka K., Kunihara T., Takekoshi N., Murakami E., Hoebeke J., Hjalmarson Å. T. Peptides derived from cardiovascular G-protein coupled receptors induce morphological changes in the heart. J. Mol. Cell. Cardiol. 1997; 29: 641–655
- Salahpour A., Angers S., Bouvier M. Functional significance of oligomerization of G-protein coupled receptors. Trends Endocrin. Metab. 2000; 11: 163–168
- Angers S., Salahpour A., Joly F., Hilairet S., Chelsky D., Dennis M., Bouvier M. Detection of B2. -adrenergic dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. USA 2000; 97: 3684–3689
- Bond R. A., Leff P., Johnson T. D., Milano C. A., Rockman H. A., McMinn T. R., Pparsundaram S., Hyek M. F., Kenakin T. P., Allen L. F., Lefkowitz R. J. Physiological effects of inverse agonists in transgenic mice with overexpression of the β-adrenoceptor. Nature 1995; 374: 272–276
- Milligan G., Rees S. Oligomerisation of G-protein coupled receptors. Annu. Rev. Med. Chem. 2000; 35: 271–279
- Lebesgue D., Wallukat G., Mijares A., Granier C., Argibay J., Hoebeke J. An agonist-like monoclonal antibody against the human β-adrenoceptor. Eur. J. Pharmacol. 1998; 348: 123–133
- Mijares A., Lebesgue D., Wallukat G., Hoebeke J. From agonist to antagonist: Fab fragments of an “agonist-like” monoclonal anti-β2-adrenoceptor antibody behave as antagonists. Mol. Pharmacol. 2000; 58: 373–379
- Mijares A., Fernandez-Gomez R., Mobini R., Hoebeke J., Escobar A. Electrophysiological parameters and Ca2+ regulation in Chagas disease: cellular measurements at the whole heart level, Abstract. Meeting of the American Biophysical Society, Boston, 2001
- Eftekhari P., Salle L., Lezoualc'h F, Mialet J., Gastineau M., Briand J. P., Isenberg D., Fournié A., Argibay J., Fischmeister R., Muller S., Hoebeke J. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur. J. Immunol. 2000; 30: 2782–2790
- Sallé L., Eftekhari P., Aupart M., Cosnay P., Hoebeke J., Argibay J. Inhibitory activity of antibodies against the human atrial 5-HT4 receptor. J. Mol. Cell. Cardiol. 2001; 33: 405–417
- Kaumann A. J., Lynham J. A., Brown A. M. Comparison of the densities of 5-HT4 receptors βi-and β2-adrenoceptors in human atrium: functional implications. Naunyn Schmiedebergs Arch. Pharmacol. 1996; 353: 592–595
- Eftekhari P., Roegel J. C., Lezoualc'h E, Fischmeister R., Imbs J. L., Hoebeke J. Induction of neonatal lupus in pups of mice immunized with synthetic peptides derived from amino acid sequences of the serotoninergic 5-HT4 receptor. Eur. J. Immunol. 2001; 31: 573–579